UArizona researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

Test tubes
Tuesday, October 25, 2022

Triple-negative breast cancer accounts for about 10 to 15% of all breast cancers. Researchers have developed a drug they hope can treat it with little to no toxic side effects.

news.arizona.edu

Tags

BIO5
Cancer Center
College of Science
Experts
Research
Science
Tech Launch Arizona
Health
Science and Technology

Subscribe to the UArizona Impact in Action newsletter to receive featured stories and event info to connect you with UArizona's research, innovation, entrepreneurial ventures, and societal impacts.

Subscribe now